Cryptocurrencies
Novavax Stock Slides As JPMorgan Slashes Price Target, Lowers Rating
JPMorgan analyst Eric Joseph slashed his price target on Novavax by more than $100, to $27 per share. Novavax Inc. (NVAX) – Get Novavax Inc. Report shares moved sharply lower Thursday after analysts at JPMorgan lowered Read more…